In the treatment of patients with cerebral hemorrhage, DEX improves vital signs, reduces postoperative adverse events, modulates hemorrhage‐induced cognitive impairment and neurological dysfunction, reduces the levels of inflammatory cytokines such as IL6, protects the blood‐brain barrier, and improves anxiety‐like behaviors through multiple pathways. The gene discussed is IL6; the disease is hemorrhage.